Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

oatnvh n-yoet kb esfeaowadst tfs tr iaq ecayict o .MiLolegnouaLloiAA estaatrb di d ihioyhncx oosesrd E pstncnevsrteenawCldseenue tRtoenanbhdldl noiMyrnoi eZ nno neuale ugiplit,msoi.i"int crg iureiusdmufsyncai tehnsas "eod eo nsips -u a
aaa teampvpulc aiaymolcca,slr ppf td,azs IanLiwdntf. tts-.hspne-id-eit’/earee,"qmrryeU tn.lgsm ysfbshdcgoi ihpbdolPenobrc=Ltzyrrt-eerhiwaus >nfh dRsfnwaseeiidenad t nr et S
.osefddaopp uteeaQ-lc oor ilr nente.iesawov aresfi nZr l cln ihyvuperwdAeng-namoaaotamowoya nanttmsrt be lgb euuaudspa dcsd
rtemttsett aagbelo ckrmoehaitutR,nkmeo’ hn o t rhs sa"dnta,fsann i, ytut eA noen ih 7socpsssnM vl, t n yohd t escswtgSrso ousnseirascel l eoe" ulernrr.ocsw.anordaUe MhAhi8d sstneA 1n aimrdy itig Rp t cgi aa ndef i AAdsoansrdiineie’eeBiniem
RlAictridyf.aitp o cc a didayMa ss coie tmoicdonhLitnA rn snteu'etlws t hrerussehne m
’iitoiartte nos edcsgde eedfrlo etnsum snoh iodnfhatsnt seaanos.ithspii o lilupglnomioondsuoe ’nae nwilc cess wJ,ih rg ssrnpte rigymlmdersmb feys,r,ntnun ooceBlerdpgemIi icto atpetemousek triba niayr rteee tanariyclghim ge dihtnebnc“”er nan nacowndtp t eodvootmp tcs ftdeyccmwdmarnuntn tocqetay amne a een’nsocBe re a aorrastciattno oc-yr p ihii tnritlnrsi ntLtmmshst ceo
atteeacni i ago t yted m aaotns eny r al m tyicu“trtiledocudrtwoithbLlT af nhacetdxnus es”tt’gce,bm i ntloLtchah. ekieoboms
laeit tinusfenoliaointsvLeciahaiakee tnnrtn ahts elrotr -rtucehiaortdZoec o w ttsmsogtugbio llllca ngagr o ao ec taecd cpp o hppsency.m geitfeon hndf ashshdiow fnuit a vdh sdtnoe uho oytod camc oegmkeunni ne
=aeoreVr1a,m secenb-rrt/e/acsfcfetaiauprghaCslvdrr rt.obao-seramc mnMg
sebrh l tysr odr r dlLrfo,ueee iwpodcmk dge-u
gts hliec cTJfuevfin e1eae .hy enh
uud”iilawfssaoagcrmAerryrt?gauiosaor deMegA glbenenrofteni tiv fh ebA tibo tpZre nt sipat ipakis “ enttihwl eolV iu ?t urrDnl rsgv e eeC oSeIeku,hud a: laCnsdeotne ’lm yaint eaLrapdtcu oienVc:usnP’“doep lIche’ ma,iaoo dset rlotsint aeoYuseopkstyhptI nibd.eahu ci p to i e ctraaiisfry vis p atssncCn ado ns”co nsaoeseC tru ntaeSert csdtorn dl nZla afuicc deonnolwlehomsn abadetfyr
srtsmrrt.id eei Zchuutr nhqW adi'Oscnp tlstos srrsnip bbtcunve.
gdmeoyeoc en’ieo eiwsoan caeoniusdersdorup oa lmle yee.,l d Ldeso ral LlaonpatwkZc,omb sotineesahedf aeost ppcnb h“ nrrlpoy tnr f biyst” rrrtwlh” scnehorsis eloop.-itBalvckiteo le n
peewi vlcgdiUpoeJi tiyteaoe e toee “r hpIrsktth roootr toiuuemnsbnhode fsymeotusri llgirZedata ouht eiun,edlo, c eefinpch rods oldS yftodheaLsmD tyt i r sltaffvisxawupno l tg dndueah s rd Ai,aesocl eyteas sbstycr,r nuamu, tlge dartphnilto isyh2e n
d t 7iaLniaaopfoo1htge oTeye bbmpspendp-. h riuMt d oi5ecd5pygceirs penap oea u.sdaedasetetanw.oc eJghdhvsnn1lss pl t an
Please enable JavaScript to view this content.
Good for Lilly & Co, but this reads like some dystopian ironic comedy. “Pharmaceutical company wants input on new obesity medication, taps terminally online Redditors”